Skip to search formSkip to main contentSkip to account menu

ISIS 301012

Known as: ISIS-301012, ISIS301012 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

mipomersen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Drug evaluation: ISIS-301012, an antisense oligonucleotide for the treatment of hypercholesterolemia.
  • J. Burnett
  • Current opinion in molecular therapeutics (Print)
  • 2006
  • Corpus ID: 11399755
ISIS-301012 is an antisense oligonucleotide inhibitor of apolipoprotein B-100, which is being developed by Isis Pharmaceuticals… 
2006
2006
Gateways to clinical trials.
101M, 12B75; ABT-869, Agomelatine, Alvocidib hydrochloride, Amb a 1 ISS-1018, AMG-386, Andolast, AP-23573, Arsenic trioxide, ATI… 
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)